"Peters Medical Research is a group of dedicated health professionals utilizing their skills and experience to advance the scientific knowledge of medicine. Our team consists of physicians, physician assistants, pharmacists, and certified clinical researchers. Our team will help identify and assist patients who may benefit from study inclusion. Peters Medical Research - partnering with patients today for tomorrow’s miracles!"

During the past decade, Peters Medical Research conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 29 clinical trials were completed, i.e. on average, 111.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 16 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peters Medical Research" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 4 trials, followed by "Ferring Pharmaceuticals" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 3 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Iroko Pharmaceuticals, LLC" with 2 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peters Medical Research" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Peters Medical Research" are "Osteoarthritis" (5 trials), "Chronic Idiopathic Constipation" (3 trials), "COVID-19" (2 trials), "Colorectal Cancer" (2 trials) and "Dyslipidemia" (2 trials). Many other conditions were trialed in "Peters Medical Research" in a lesser frequency.

Most popular intervention types in "Peters Medical Research" are "Drug" (53 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Vonoprazan" (4 trials), "Diclofenac" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peters Medical Research" are 54 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Peters Medical Research". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Peters Medical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Peters Medical Research, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".